In this podcast, Michael Peters, MD, talks about his team's cross-sectional analysis on the use of blood eosinophils and IL-6 as predictive biomarkers of the exacerbation-prone asthma phenotype over 3...
In this podcast, Brooke Nichols, PhD, answers our questions about her team's novel and pragmatic metric to evaluate and compare pre-exposure prophylaxis program effectiveness using routine implementation...
Dr Karpouzas talks about his study that evaluated whether biologic disease-modifying antirheumatic drugs reduce long-term risk of cardiovascular events in patients with rheumatoid arthritis, as well as...
In this podcast, Dr Michos, from Johns Hopkins University School of Medicine, talks about her latest study on how the influenza vaccine effects mortality and morbidity outcomes among patients with...
Michael Blaha, MD, MPH, discusses his team’s study on whether troponin levels and coronary artery calcium score can predict future atherosclerotic cardiovascular disease risk, the use of aspirin and statins...
The co-chairs of the writing committee for the “2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease” answer our questions about the updated guideline and why aspirin is no longer...
David Malebranche, MD, MPH, talks about his session from the 2019 National HIV Prevention Conference, titled "We Are Family: Helping Patients Navigate the HIV Care Continuum." He discusses the current HIV...
